Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

A polymorphism study of the human Agouti gene and its association with MC1R.

Voisey J, Box NF, van Daal A.

Pigment Cell Res. 2001 Aug;14(4):264-7.

PMID:
11549109
2.

Melanocortin-1 receptor variant R151C modifies melanoma risk in Dutch families with melanoma.

van der Velden PA, Sandkuijl LA, Bergman W, Pavel S, van Mourik L, Frants RR, Gruis NA.

Am J Hum Genet. 2001 Oct;69(4):774-9. Epub 2001 Aug 7.

3.

MC1R genotype modifies risk of melanoma in families segregating CDKN2A mutations.

Box NF, Duffy DL, Chen W, Stark M, Martin NG, Sturm RA, Hayward NK.

Am J Hum Genet. 2001 Oct;69(4):765-73. Epub 2001 Aug 8.

4.

Interaction of glutathione S-transferase M1 and T1 genotypes and malignant melanoma.

Kanetsky PA, Holmes R, Walker A, Najarian D, Swoyer J, Guerry D, Halpern A, Rebbeck TR.

Cancer Epidemiol Biomarkers Prev. 2001 May;10(5):509-13.

5.

Melanocortin-1 receptor gene variants determine the risk of nonmelanoma skin cancer independently of fair skin and red hair.

Bastiaens MT, ter Huurne JA, Kielich C, Gruis NA, Westendorp RG, Vermeer BJ, Bavinck JN; Leiden Skin Cancer Study Team.

Am J Hum Genet. 2001 Apr;68(4):884-94. Epub 2001 Mar 16.

6.

The melanocortin 1 receptor is the principal mediator of the effects of agouti signaling protein on mammalian melanocytes.

Abdel-Malek ZA, Scott MC, Furumura M, Lamoreux ML, Ollmann M, Barsh GS, Hearing VJ.

J Cell Sci. 2001 Mar;114(Pt 5):1019-24.

7.

Evidence for variable selective pressures at MC1R.

Harding RM, Healy E, Ray AJ, Ellis NS, Flanagan N, Todd C, Dixon C, Sajantila A, Jackson IJ, Birch-Machin MA, Rees JL.

Am J Hum Genet. 2000 Apr;66(4):1351-61. Epub 2000 Mar 24.

8.

Melanocortin-1 receptor polymorphisms and risk of melanoma: is the association explained solely by pigmentation phenotype?

Palmer JS, Duffy DL, Box NF, Aitken JF, O'Gorman LE, Green AC, Hayward NK, Martin NG, Sturm RA.

Am J Hum Genet. 2000 Jan;66(1):176-86.

9.

Loss of function mutations of the human melanocortin 1 receptor are common and are associated with red hair.

Schiöth HB, Phillips SR, Rudzish R, Birch-Machin MA, Wikberg JE, Rees JL.

Biochem Biophys Res Commun. 1999 Jul 5;260(2):488-91.

PMID:
10403794
10.

Absence of genetic variation in some obesity candidate genes (GLP1R, ASIP, MC4R, MC5R) among Pima indians.

Norman RA, Permana P, Tanizawa Y, Ravussin E.

Int J Obes Relat Metab Disord. 1999 Feb;23(2):163-5.

PMID:
10078851
11.

Human pigmentation phenotype: a point mutation generates nonfunctional MSH receptor.

Frändberg PA, Doufexis M, Kapas S, Chhájlani V.

Biochem Biophys Res Commun. 1998 Apr 17;245(2):490-2.

PMID:
9571181
12.

Interaction of Agouti protein with the melanocortin 1 receptor in vitro and in vivo.

Ollmann MM, Lamoreux ML, Wilson BD, Barsh GS.

Genes Dev. 1998 Feb 1;12(3):316-30.

13.

Recommendations for a nomenclature system for human gene mutations. Nomenclature Working Group.

Antonarakis SE.

Hum Mutat. 1998;11(1):1-3. No abstract available.

PMID:
9450896
14.

Characterization of melanocyte stimulating hormone receptor variant alleles in twins with red hair.

Box NF, Wyeth JR, O'Gorman LE, Martin NG, Sturm RA.

Hum Mol Genet. 1997 Oct;6(11):1891-7.

PMID:
9302268
15.

Agouti signaling protein inhibits melanogenesis and the response of human melanocytes to alpha-melanotropin.

Suzuki I, Tada A, Ollmann MM, Barsh GS, Im S, Lamoreux ML, Hearing VJ, Nordlund JJ, Abdel-Malek ZA.

J Invest Dermatol. 1997 Jun;108(6):838-42.

16.

Clinically recognized dysplastic nevi. A central risk factor for cutaneous melanoma.

Tucker MA, Halpern A, Holly EA, Hartge P, Elder DE, Sagebiel RW, Guerry D 4th, Clark WH Jr.

JAMA. 1997 May 14;277(18):1439-44.

PMID:
9145715
17.

Effects of recombinant agouti-signaling protein on melanocortin action.

Yang YK, Ollmann MM, Wilson BD, Dickinson C, Yamada T, Barsh GS, Gantz I.

Mol Endocrinol. 1997 Mar;11(3):274-80.

PMID:
9058374
18.

Binding of melanotropic hormones to the melanocortin receptor MC1R on human melanocytes stimulates proliferation and melanogenesis.

Suzuki I, Cone RD, Im S, Nordlund J, Abdel-Malek ZA.

Endocrinology. 1996 May;137(5):1627-33.

PMID:
8612494
19.

A suggested nomenclature for designating mutations.

Beaudet AL, Tsui LC.

Hum Mutat. 1993;2(4):245-8. No abstract available.

PMID:
8401532
20.

Supplemental Content

Support Center